Global Drug Discovery Informatics Market Size, Trends, and Analysis- Forecasts To 2026 By Solution (Services, Software), By Application (Drug Discovery, Drug Development), By Function (Docking, Library & Database Preparation, Sequencing & Target Data Analysis, Molecular Modeling, Other Functions), By End-User (Contract Research Organizations, Pharmaceutical Companies, Biotechnology Companies, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Drug Discovery Informatics helps users to work with huge amounts of data &assists in the management of data collection, analysis, and interpretation. These informatics platforms for drug discovery use bioinformatics algorithms to process data and use several silico models to analyze the data collected. During the projected timeline, growing expenditure on R&D activities and increasing demand for customized medicines are expected to drive growth. Growing funding and demand for orphan drug research & novel drug discovery is also expected to accelerate demand for drug discovery informatics in the market. Furthermore, the increasing use of cloud-based services clubbed with the increasing usage of information technology in data mining and analysis has helped the market grow exponentially from 2020 to 2026.
The market can be split into drug exploration and drug production based on the application segment. The drug development application segment will be the largest market shareholder due to the increasing number of preclinical testing activities.
As per the solution-based outlook, the segment of the market is services and software. The biggest market share in 2019 was the software attributed to the effective and fast management of data generated using drug discovery software solutions in the drug discovery process.Furthermore, the advantages of informatics software in drug discovery are anticipated to boost the growth for the solution market throughout the forecast period.
According to the function type, this market can be segregated into five segments namely, docking, library & database preparation, sequencing & target data analysis, and molecular modeling, among other functions. The sequencing & target data analysissegment of this market would be the dominating segment as compared to the other functions. This is attributed to the increasing need for sequencing analysis of blockbuster drugs, new entity medicines, and personalized medicines.
Based on the analysis, the end-user market can be divided into three segments: contract research organizations, pharmaceutical companies, and biotechnology companies, among others. In2019, the pharmaceutical firm is expected to be the largest shareholder. This informatics software is commonly used by pharmaceutical companies for pre-clinical research and development, target recognition, compound monitoring, and lead identification, and streamlining their process of drug discovery.
It is anticipated that the North American region will boost the market shareholder over the expected time frame from 2020-2026. Rising investment in well-established CROs over the projected timeframe is expected. Increasing technological advances in data analytics and mining and rising drug discovery R&D investments would accelerate the development of market growth in the region.On the other hand, due to the growth of biopharmaceutical companies and the rising number of contract research organizations, the Asia Pacific will be the fastest-growing region.
The major players competing in this market are Jubilant Life Sciences, CDD, IBM, Accenture, Dassault Systèmes, Evotec Ag, Infosys Limited, Cognizant, Albany Molecular Research, Selvita, GVK Biosciences, IO Informatics, Schrödinger, Certara, Charles River Laboratories International, Clarivate Analytics, Perkinelmer, Eurofins, Scientific Thermo Fisher Scientific, and Openeye Scientific Software, among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In September 2019, Evotec partnered with Takeda Pharmaceutical Company, Ltd. to develop 5 drug discovery initiatives with Evotec clinical candidates across various therapy areas.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Drug Discovery Informatics Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Drug Discovery Informatics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?